Hmm, in that gibberish I believe you are asserting that Bioamber should be owed a royalty for use of its components? No problem, just point me to the royalty provision in the Monitors reports. Or any report or document.
While we're chatting, any chance you will change your mind and answer my question about whether you believe there are companies that go bankrupt and the non canceled shares sit in shareholders accounts for many years with no chance of being reinstated?